These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10706635)

  • 1. Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release.
    Faig M; Bianchet MA; Talalay P; Chen S; Winski S; Ross D; Amzel LM
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3177-82. PubMed ID: 10706635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase).
    Zhao Q; Yang XL; Holtzclaw WD; Talalay P
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1669-74. PubMed ID: 9050836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction.
    Li R; Bianchet MA; Talalay P; Amzel LM
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8846-50. PubMed ID: 7568029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of NAD(P)H:quinone reductase: Ab initio studies of reduced flavin.
    Cavelier G; Amzel LM
    Proteins; 2001 Jun; 43(4):420-32. PubMed ID: 11340659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
    Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
    Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, function, and mechanism of cytosolic quinone reductases.
    Bianchet MA; Erdemli SB; Amzel LM
    Vitam Horm; 2008; 78():63-84. PubMed ID: 18374190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
    Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM
    Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human NAD(P)H:quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups.
    Mendoza MF; Hollabaugh NM; Hettiarachchi SU; McCarley RL
    Biochemistry; 2012 Oct; 51(40):8014-26. PubMed ID: 22989153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function studies of DT-diaphorase (NQO1) and NRH: quinone oxidoreductase (NQO2).
    Chen S; Wu K; Knox R
    Free Radic Biol Med; 2000 Aug; 29(3-4):276-84. PubMed ID: 11035256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based development of anticancer drugs: complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones.
    Faig M; Bianchet MA; Winski S; Hargreaves R; Moody CJ; Hudnott AR; Ross D; Amzel LM
    Structure; 2001 Aug; 9(8):659-67. PubMed ID: 11587640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A site-directed mutagenesis study at Lys-113 of NAD(P)H:quinone-acceptor oxidoreductase: an involvement of Lys-113 in the binding of the flavin adenine dinucleotide prosthetic group.
    Tedeschi G; Deng PS; Chen HH; Forrest GL; Massey V; Chen S
    Arch Biochem Biophys; 1995 Aug; 321(1):76-82. PubMed ID: 7639539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of human quinone reductase type 2, a metalloflavoprotein.
    Foster CE; Bianchet MA; Talalay P; Zhao Q; Amzel LM
    Biochemistry; 1999 Aug; 38(31):9881-6. PubMed ID: 10433694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, biochemical and kinetic properties of recombinant Pst2p from Saccharomyces cerevisiae, a FMN-dependent NAD(P)H:quinone oxidoreductase.
    Koch K; Hromic A; Sorokina M; Strandback E; Reisinger M; Gruber K; Macheroux P
    Biochim Biophys Acta Proteins Proteom; 2017 Aug; 1865(8):1046-1056. PubMed ID: 28499769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone oxidoreductase(1.).
    Lienhart WD; Gudipati V; Uhl MK; Binter A; Pulido SA; Saf R; Zangger K; Gruber K; Macheroux P
    FEBS J; 2014 Oct; 281(20):4691-4704. PubMed ID: 25143260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of nitroaromatic compounds by NAD(P)H:quinone oxidoreductase (NQO1): the role of electron-accepting potency and structural parameters in the substrate specificity.
    Miseviciene L; Anusevicius Z; Sarlauskas J; Cenas N
    Acta Biochim Pol; 2006; 53(3):569-76. PubMed ID: 16929382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steric hindrance controls pyridine nucleotide specificity of a flavin-dependent NADH:quinone oxidoreductase.
    Ball J; Reis RAG; Agniswamy J; Weber IT; Gadda G
    Protein Sci; 2019 Jan; 28(1):167-175. PubMed ID: 30246917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones.
    Gaikwad NW; Rogan EG; Cavalieri EL
    Free Radic Biol Med; 2007 Nov; 43(9):1289-98. PubMed ID: 17893042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic and docking studies of the interaction of quinones with the quinone reductase active site.
    Zhou Z; Fisher D; Spidel J; Greenfield J; Patson B; Fazal A; Wigal C; Moe OA; Madura JD
    Biochemistry; 2003 Feb; 42(7):1985-94. PubMed ID: 12590585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD(P)H:(Quinone-Acceptor) Oxidoreductase of Tobacco Leaves Is a Flavin Mononucleotide-Containing Flavoenzyme.
    Sparla F; Tedeschi G; Trost P
    Plant Physiol; 1996 Sep; 112(1):249-258. PubMed ID: 12226388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and mechanism of NAD[P]H:quinone acceptor oxidoreductases (NQO).
    Bianchet MA; Faig M; Amzel LM
    Methods Enzymol; 2004; 382():144-74. PubMed ID: 15047101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.